Carl A.Kukkonen III

Partner

(T) 1.858.314.1178

Connect:

Share

An acknowledged leader in the profession, Carl Kukkonen has more than 20 years of experience in strategic intellectual property counseling and litigation. Specifically, Carl advises clients on patent infringement and validity, preparation and prosecution of patent applications, prelitigation case assessment, active patent litigation, IP due diligence, and brand protection matters.

Carl has represented clients in a wide range of industries including SAP, Dräger, Cylance, Qualcomm, Sempra Energy, Aerospace Corporation, Dexcom, CareFusion, Fair Isaac Corporation, First Data Corporation, Fox Interactive Media, Tencent, and many others.

Carl has prosecuted, analyzed, and litigated patents across various technologies including high-technology/software, medical devices, and energy technology. His experience in the high-tech arena includes database technologies, cybersecurity, artificial intelligence and machine learning, ridesharing/carpooling, robotics, enterprise software, cloud computing, big data, blockchains, mobile phone software and hardware, telecommunications, IoT, semiconductors, nanotechnology, optical devices, computer and microchip architecture, virtual and augmented reality, and signal and image processing.

In the area of medical devices he has handled matters related to medication delivery devices, wireless health care, digital health, bedside patient monitors, incubators, infusion pumps, physiological sensors including cardiac monitors and blood pressure devices, ophthalmic technologies, and bone fixation plates and systems.

His energy technology experience includes process and atmospheric sensors, solar panels and control systems, utility-scale energy distribution systems, energy efficiency technologies, water and wind turbines, fuel cells, and water purification systems.

Experience

  • Cylance acquired by BlackBerry for $1.4 billionJones Day advised Cylance, an artificial intelligence and cybersecurity leader, in its $1.4 billion acquisition by BlackBerry Limited, plus the assumption of unvested employee incentive awards.
  • Modern Media Acquisition enters merger agreement with Akazoo Ltd.Jones Day is advising Modern Media Acquisition Corp. ("MMDM"), a special purpose acquisition company, in its business combination with Akazoo Limited, a U.K.- based digital music streaming platform specializing in emerging markets.
  • Sempra Energy unit PXiSE Energy completes equity financing with Mitsui & Co.Jones Day advised Sempra Energy in connection with the issuance by its subsidiary, PXiSE Energy Solutions, LLC, of up to a 20 percent equity investment to Mitsui & Co., Ltd., as well as the negotiation and entering in of a strategic collaboration agreement for the development and sale of PXiSE's technology.
  • Sempra Energy develops patent portfolio directed to advanced electric grid technologiesJones Day is advising Sempra Energy and its subsidiary PXiSE Energy Solutions with the development of a patent portfolio directed to software and hardware solutions directed to improving the efficiency and efficacy of the electrical grid.
  • Multinational software corporation develops patent portfolio leveraging blockchain technologiesJones Day is assisting a multinational software corporation in developing a patent portfolio leveraging blockchain technologies.
  • Cylance develops worldwide trademark portfolio for cybersecurity softwareJones Day advises Cylance, Inc. on the development and enforcement of its worldwide trademark portfolio directed to leading machine learning-based cybersecurity software and related services.
  • Dexcom obtains stay of patent infringement action filed by AgaMatrixJones Day is defending Dexcom, Inc. in a patent infringement action before the United States District Court for the District of Oregon (Portland Division).
  • Cylance develops patent portfolio directed to advanced cybersecurity software utilizing machine learning / artificial intelligenceJones Day is advising Cylance Inc. with the development of a patent portfolio directed to advanced cybersecurity software utilizing machine learning / artificial intelligence.
  • Canaccord Genuity and Cowen and Company underwrite $30 million public offering of Common Stock by AvingerJones Day represented Canaccord Genuity, Inc. and Cowen and Company, as lead underwriters, in connection with a $32 million follow-on public offering of Common Stock by Avinger, Inc., a commercial-stage medical device company that designs, manufactures, and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease.
  • Cylance raises $100 million in Series D roundJones Day represented Cylance Inc., a cybersecurity company that applies artificial intelligence algorithms to predictively identify and stop malware and advanced threats, in connection with its issuance of $100 million of Series D Convertible Preferred Stock in a private placement.
  • SAP establishes diverse patent portfolio directed to software and database innovationsJones Day represents a leading enterprise software and database developer SAP SE in managing patent portfolios directed to diverse innovations including database technologies, mobility, UX, cloud computing, and big data.
  • Aerospace Corporation establishes cutting edge patent portfolio directed to diverse terrestrial and space innovationsJones Day represents The Aerospace Corporation in strategically developing its patent portfolio directed to diverse innovations including space and terrestrial communication systems and protocols, advanced sensors, optics, and related manufacturing processes.
  • Draeger establishes global patent portfolio directed to diverse medical devices and safety equipmentJones Day represents medical device manufacturer Draeger Medical Systems, Inc. in managing global patent portfolios relating to patient monitors (both hardware and related software), physiological sensors, incubators, and breathing apparatus.
  • ANSYS expands global intellectual property portfolioJones Day provides IP advice to ANSYS, Inc. and assists with the prosecution and management of its international patent portfolio related to engineering simulation for assisting the world's most innovative companies in delivering radically better products to their customers.

    • The following represents experience acquired prior to joining Jones Day.

    Represented CareFusion in expanding their global patent portfolio directed to software and hardware aspects of infusion systems as well as related disposables.

    Represented Fair Isaac Corporation (FICO) in the strategic development of a portfolio directed to advanced techniques for credit scoring, decisioning, and transaction fraud technologies using machine learning models and analytics.

    Represented Endress+Hauser in establishing a global patent portfolio directed to advanced spectrometers for use in industrial processing including oil and gas.

    Represented Intel Corporation in establishing a diverse global patent portfolio directed to microprocessors, data processing, and data transmission.

    Represented Ericsson in further developing their patent portfolio directed to mobile communications protocols and networking hardware.

    Represented public medical technology company in establishing a patent portfolio directed to bone fixation plates and elements.

    View All

    August 2019 White Paper

    Patenting Digital Health Innovations Incorporating AI in View of USPTO's Recent Subject Matter Eligibility Guidance

    July 2019 Blogs

    Precedential PTAB Order Addresses Witness Examination, PTAB Litigation Blog

    May 2019 Blogs

    POP: Does A Complaint Without Standing Trigger the IPR Time Bar?, PTAB Litigation Blog

    March 2019 Blogs

    PTAB Issues Updated Guidance on Motions to Amend in AIA Trials, PTAB Litigation Blog

    January 2019 Blogs

    Battling Boredom While Building Virtual Cities: PTAB Denies Claims as Patent-Ineligible, PTAB Litigation Blog

    January 2019 Commentaries

    USPTO Releases New Guidance on Patent Subject Matter Eligibility

    November 2018 Blogs

    Assignor Estoppel Does Not Apply to IPRs, PTAB Litigation Blog

    October 2018 Commentaries

    Patenting Artificial Intelligence and Machine Learning Innovations in Europe

    October 2018 Blogs

    Federal Circuit Affirms Trade Conference Catalog Qualifies As Prior Art, PTAB Litigation Blog

    August 2018 Blogs

    Submissions of Supplemental Information in IPRs Subject to Extra Requirements, PTAB LItigation Blog
    View All

    Additional Publications

    • January 2019
      Intellectual Property Owners Association (IPO) - 35 USC 101 Subject Matter Eligibility Cases Involving Software-Related Inventions
    • October 11, 2018
      An Introduction to the Risks of AI for General Counsel, Corporate Counsel
    • June 2018
      Protecting Artificial Intelligence Innovations Through Patents, IP Litigator
    • November 21, 2015
      Indefiniteness: Are You Reasonably Certain?
    • 2014
      USPTO Issues Interim Guidance on Patent Eligibility Under §101
    • 2011
      The Law That Protects the Appearance of Your Website
    • 2010
      USPTO Expands Green Technology Pilot Program to Cover More Inventions, Energy & Clean Technology
    • 2008
      A Look at the Changing Landscape of Patent Prosecution, San Diego Business Journal
    • 2007
      More Companies Seek Patents in Unconventional Areas, Boston Business Journal
    • 2007
      Emerging Patent Issues in Cleantech, IP Law 360 / Energy Law 360
    • 2007
      Expanding Preconceptions of Patentable Matter, bizSanDiego
    • 2007
      When in Doubt, Spell It Out: Complying with a Patentee's Duty of Disclosure, San Diego Daily Transcript

    Speaking Engagements

    • August 1, 2019
      Strategies for Protecting AI Innovations
    • June 2019
      IP Protection Trends in Artificial Intelligence, Bulgaria
    • June 2019
      IP Protection Trends in Artificial Intelligence, Germany
    • June 2019
      IP Protection Trends in Artificial Intelligence
    • June 2019
      Artificial Intelligence: Emerging Issues and Strategic IP Protection
    • September 20, 2018
      IP Protection for Artificial intelligence and Big Data Innovations in the Life Sciences, Boston Bar Association Life Sciences Conference
    • September 2018
      Patent Strategies for Medical Technologies Utilizing Artificial Intelligence
    • July 2018
      Artificial Intelligence Deployed in Medical Devices: Patent Strategies and Challenges
    • April 2018
      Patent Claim Drafting for Software / Artificial Intelligence Technologies (University of California, San Diego)
    • January 23, 2018
      Protecting Your AI-Related Innovations: Trade Secrets or Patents?
    • June 2017
      Big Data and Cloud Computing: Strategies for Patent and Trade Secret Protection
    • January 2017
      Strategic Patent Protection of Software and AI-Based Innovations
    • November 2016
      Litigation-Focused Patent Prosecution
    • October 2016
      Update On Patentability Of Computer Implemented Inventions
    • May 2016
      Update on U.S. Protection of Computer Implemented Inventions
    • January 20, 2016
      Recent Developments in IP Law and Their Implications
    • November 17, 2015
      IP ConfEx: Becoming a Better IP professional and Legal Advisor: Soft Skills for Navigating a Contentious, Globalized Environment
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.